258 related articles for article (PubMed ID: 34258767)
1. Long-term clinical outcomes of periodontal regeneration with enamel matrix derivative: A retrospective cohort study with a mean follow-up of 10 years.
De Ry SP; Roccuzzo A; Lang NP; Sculean A; Salvi GE
J Periodontol; 2022 Apr; 93(4):548-559. PubMed ID: 34258767
[TBL] [Abstract][Full Text] [Related]
2. Four-year results following treatment of intrabony periodontal defects with an enamel matrix derivative alone or combined with a biphasic calcium phosphate.
Pietruska M; Pietruski J; Nagy K; Brecx M; Arweiler NB; Sculean A
Clin Oral Investig; 2012 Aug; 16(4):1191-7. PubMed ID: 21881869
[TBL] [Abstract][Full Text] [Related]
3. Ten-year results following treatment of intrabony defects with an enamel matrix protein derivative combined with either a natural bone mineral or a β-tricalcium phosphate.
Döri F; Arweiler NB; Szántó E; Agics A; Gera I; Sculean A
J Periodontol; 2013 Jun; 84(6):749-57. PubMed ID: 22873657
[TBL] [Abstract][Full Text] [Related]
4. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
[TBL] [Abstract][Full Text] [Related]
5. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study.
Sculean A; Windisch P; Chiantella GC; Donos N; Brecx M; Reich E
J Clin Periodontol; 2001 May; 28(5):397-403. PubMed ID: 11350501
[TBL] [Abstract][Full Text] [Related]
6. Five-year results following regenerative periodontal surgery with an enamel matrix derivative in patients with different smoking status.
De Ry SP; Pagnamenta M; Ramseier CA; Roccuzzo A; Salvi GE; Sculean A
Quintessence Int; 2022 Oct; 53(10):832-838. PubMed ID: 36169272
[TBL] [Abstract][Full Text] [Related]
7. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects.
Heden G; Wennström JL
J Periodontol; 2006 Feb; 77(2):295-301. PubMed ID: 16460257
[TBL] [Abstract][Full Text] [Related]
8. Long-term stability of infrabony defects treated with enamel matrix derivative alone: A retrospective two-centre cohort study.
Koronna I; Schacher B; Dahmer I; Nickles K; Sonnenschein SK; Kim TS; Eickholz P; Petsos H
J Clin Periodontol; 2023 Jul; 50(7):996-1009. PubMed ID: 37051653
[TBL] [Abstract][Full Text] [Related]
9. Five-year results evaluating the effects of platelet-rich plasma on the healing of intrabony defects treated with enamel matrix derivative and natural bone mineral.
Döri F; Arweiler N; Húszár T; Gera I; Miron RJ; Sculean A
J Periodontol; 2013 Nov; 84(11):1546-55. PubMed ID: 23327604
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
[TBL] [Abstract][Full Text] [Related]
11. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
[TBL] [Abstract][Full Text] [Related]
12. Enamel matrix proteins in the regenerative therapy of deep intrabony defects.
Tonetti MS; Lang NP; Cortellini P; Suvan JE; Adriaens P; Dubravec D; Fonzar A; Fourmousis I; Mayfield L; Rossi R; Silvestri M; Tiedemann C; Topoll H; Vangsted T; Wallkamm B
J Clin Periodontol; 2002 Apr; 29(4):317-25. PubMed ID: 11966929
[TBL] [Abstract][Full Text] [Related]
13. The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
Sculean A; Blaes A; Arweiler N; Reich E; Donos N; Brecx M
J Periodontol; 2001 Feb; 72(2):190-5. PubMed ID: 11288792
[TBL] [Abstract][Full Text] [Related]
14. Radiographic angle width as predictor of clinical outcomes following regenerative periodontal therapy with enamel matrix derivative: a retrospective cohort study with a mean follow-up of at least 10 years.
Roccuzzo A; Ettmayer J; De Ry SP; Imber JC; Sculean A; Salvi GE
Quintessence Int; 2023 May; 54(5):384-392. PubMed ID: 36661359
[TBL] [Abstract][Full Text] [Related]
15. The effect of postsurgical administration of a selective cyclo-oxygenase-2 inhibitor on the healing of intrabony defects following treatment with enamel matrix proteins.
Sculean A; Berakdar M; Donos N; Auschill TM; Arweiler NB
Clin Oral Investig; 2003 Jun; 7(2):108-12. PubMed ID: 12720115
[TBL] [Abstract][Full Text] [Related]
16. Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
Sculean A; Donos N; Blaes A; Lauermann M; Reich E; Brecx M
J Periodontol; 1999 Mar; 70(3):255-62. PubMed ID: 10225541
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
[TBL] [Abstract][Full Text] [Related]
18. Apical approach in periodontal reconstructive surgery with enamel matrix derivate and enamel matrix derivate plus bone substitutes: a randomized, controlled clinical trial.
Moreno Rodríguez JA; Ortiz Ruiz AJ
Clin Oral Investig; 2022 Mar; 26(3):2793-2805. PubMed ID: 34791548
[TBL] [Abstract][Full Text] [Related]
19. Ten-year results following treatment of intra-bony defects with enamel matrix proteins and guided tissue regeneration.
Sculean A; Kiss A; Miliauskaite A; Schwarz F; Arweiler NB; Hannig M
J Clin Periodontol; 2008 Sep; 35(9):817-24. PubMed ID: 18647201
[TBL] [Abstract][Full Text] [Related]
20. Supracrestal soft tissue preservation with enamel matrix proteins in treatment of deep intrabony defects.
Trombelli L; Bottega S; Zucchelli G
J Clin Periodontol; 2002 May; 29(5):433-9. PubMed ID: 12060426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
